ImmuPharma plc (LON:IMM – Get Rating)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 5.94 ($0.07) and traded as low as GBX 4.50 ($0.05). ImmuPharma shares last traded at GBX 4.82 ($0.06), with a volume of 204,449 shares traded.
ImmuPharma Trading Down 31.0 %
The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.02. The company has a 50-day simple moving average of GBX 5.85 and a 200 day simple moving average of GBX 5.94. The firm has a market cap of £9.85 million and a PE ratio of -0.91.
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco’s Post-Earnings Price Weakness A Good Time To Buy?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.